http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018229002-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d938aa1b75b88f5a116a30536dc97b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0057
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0029
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
filingDate 2018-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cb319cad6b207198b80397f904caced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb74b2681954d5141ebb37ffca9d3945
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30e9568c9205ab42d24a755876fd6d63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dc922da5f2394c18a70289ad40e2015
publicationDate 2018-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2018229002-A1
titleOfInvention Seeping flow anti-clotting blood catheter
abstract A catheter includes an elongated tube having a distal end and a proximal end. The elongated tube includes porous material having an interior and an exterior face. The interior face defines a lumen along a central axis of the elongated tube. The porous material is configured to flow a fluid between the interior face and the exterior face and to seep the fluid out of the porous material through the exterior face and interior face. A lining covers at least a portion of the exterior face and substantially limits perfusion through the exterior face at the portion of the exterior face covered by the lining. The catheter is impregnated with a material that prevents buildup of material on one of an inner face or an outer face of the catheter or the lining is coated with one or more of an anticoagulant, antibiotic, or antithrombotic.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529462-B2
priorityDate 2014-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005113798-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012310085-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003105453-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962519-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100862683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310

Total number of triples: 34.